SCHOTT Pharma AG & Co. KGaA, DE000A3ENQ51

SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51

18.12.2025 - 12:27:51

SCHOTT Pharma AG & Co. KGaA: Reinhard Mayer, buy


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

18.12.2025 / 12:26 CET/CEST
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Reinhard
Last name(s): Mayer

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
SCHOTT Pharma AG & Co. KGaA

b) LEI
529900TU48UE99NHEY88 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A3ENQ51

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
15.3600 EUR 7,219.20 EUR
15.3800 EUR 1,999.40 EUR
15.4000 EUR 10,010.00 EUR
14.6000 EUR 25,550.00 EUR

d) Aggregated information
Price Aggregated volume
14.9262 EUR 44,778.6000 EUR

e) Date of the transaction
18/12/2025; UTC+1

f) Place of the transaction
Name: Xetra
MIC: XETR



18.12.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany
Internet: https://ir.schott-pharma.com/

 
End of News EQS News Service

102564  18.12.2025 CET/CEST
@ dgap.de